GW&K Investment Management, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
GW&K Investment Management, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$13,000
-99.8%
60
-99.9%
0.00%
-100.0%
Q4 2020$6,183,000
+16.7%
53,573
-1.6%
0.06%
-5.8%
Q3 2020$5,298,000
-22.0%
54,418
-1.7%
0.07%
-27.4%
Q2 2020$6,791,000
+37.1%
55,336
-2.2%
0.10%
+9.2%
Q1 2020$4,955,000
-15.7%
56,583
+0.7%
0.09%
+11.5%
Q4 2019$5,876,000
+35.3%
56,193
+48.9%
0.08%
+27.9%
Q3 2019$4,342,000
-4.1%
37,745
+43.7%
0.06%
-11.6%
Q2 2019$4,529,000
+1.2%
26,271
-1.0%
0.07%
-4.2%
Q1 2019$4,474,000
+50.1%
26,540
-13.3%
0.07%
+22.0%
Q4 2018$2,980,00030,5960.06%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders